About AlleSense
AlleSense is a company based in Melbourne (Australia) founded in 2020. It operates as a B2B. AlleSense has raised $3.49 million across 2 funding rounds from investors including Breakthrough Victoria. AlleSense offers products and services including NanoMslide. AlleSense operates in a competitive market with competitors including Akoya Biosciences, Scopio Labs, Morphle, PreciPoint and Optra SCAN, among others.
- Headquarter Melbourne, Australia
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.49 M (USD)
in 2 rounds
-
Latest Funding Round
$1.79 M (USD), Seed
May 28, 2026
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AlleSense
AlleSense offers a comprehensive portfolio of products and services, including NanoMslide.
Provides label-free tissue imaging using coated slides for faster diagnostics
Funding Insights of AlleSense
AlleSense has successfully raised a total of $3.49M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.79 million completed in May 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AlleSense
AlleSense has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Breakthrough Victoria.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for AlleSense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AlleSense
Investment portfolio details for AlleSense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AlleSense
Detailed financials for AlleSense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Allesense Comparisons
Peer comparison for AlleSense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AlleSense
AlleSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akoya Biosciences, Scopio Labs, Morphle, PreciPoint and Optra SCAN, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of solutions for rapid proteomic profiling
|
|
| Locked | Locked | Locked |
Provider of computational imaging-based digital microscopes & image analysis tools
|
|
| Locked | Locked | Locked |
Provider of robotic microtomes and digital pathology scanners. These devices automate tissue processing and slide scanning for anatomical pathology, dermatopathology, and hematology. The scanners offer high-resolution imaging and integrated workflows, facilitating efficient digital microscopy and telepathology applications. Various models cater to different throughput needs, from single-slide to high-volume batch processing. The company also offers AI-powered requisition data entry solutions.
|
|
| Locked | Locked | Locked |
Digital microscopes and micro-positioning systems are developed.
|
|
| Locked | Locked | Locked |
Integrated digital pathology solutions.
|
|
| Locked | Locked | Locked |
Portable scanning microscopes are supplied for medical researchers.
|
Detailed competitors of AlleSense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Allesense
Complete news archive for AlleSense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AlleSense
AlleSense was founded in 2020 and raised its 1st funding round 3 years after it was founded.
AlleSense is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.
AlleSense is a funded company, having raised a total of $3.49M across 2 funding rounds to date.
AlleSense specializes in developing NanoMslide, a patented technology that uses specially coated microscope slides to generate colorized images without chemicals. This innovation enhances optical imaging by providing sample composition and morphology information, fitting seamlessly into existing workflows. Based in Australia and linked to La Trobe University, the company targets medical and research sectors for applications in digital pathology and tissue analysis, aiming to reduce diagnosis time and improve accuracy.
AlleSense's top competitors include Akoya Biosciences, Optra SCAN and Scopio Labs.
AlleSense offers NanoMslide.
AlleSense has 1 investor. Key investors include Breakthrough Victoria.